Secondary Adjuvant Long Term Study With Arimidex
NCT00295620
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
3484
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Anastrozole
Sponsor
AstraZeneca